Concepedia

Luisa Kirschner

LK

Statistics

Publications

5

Citations

553

H-Index

5

Active since

2020

Affiliations

University of Würzburg(Current)

Harvard University

Helmholtz Institute for RNA-based Infection Research

Center for Systems Biology

Luisa Kirschner is an author at University of Würzburg specializing in sars-cov-2 infection, molecular virology, and pharmacology.

Publications per year

2020–2021

5

Publications

5

The SARS-CoV-2 RNA–protein interactome in infected human cells

Nora Schmidt, Caleb A. Lareau, Hasmik Keshishian et al. · Nature Microbiology · 2020 · 354 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Melissa Zimniak, Luisa Kirschner, Helen Hilpert et al. · Scientific Reports · 2021 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2

Melissa Zimniak, Luisa Kirschner, Helen Hilpert et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A direct RNA-protein interaction atlas of the SARS-CoV-2 RNA in infected human cells

Nora Schmidt, Caleb A. Lareau, Hasmik Keshishian et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 21 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

Facile Synthesis and In Vitro Activity of N-Substituted 1,2-Benzisothiazol-3(2H)-ones against Dengue Virus NS2BNS3 Protease

Farwa Batool, Muhammad Saeed, Hafiza Nosheen Saleem et al. · Pathogens · 2021 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 5